Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...

Protagonist Therapeutics broke out Monday after the company's drug topped its rival from Bristol in a psoriasis study.

Strong demand for the company's Skyrizi and Rinvoq autoimmune therapeutics ... aesthetics brands Botox and Juvederm as anti-aging skin treatments. This diversification, coupled with a long ...

Additionally, the company commercializes the high-profile aesthetics brands Botox and Juvederm as anti-aging skin treatments ... with two blockbuster drugs: Skyrizi and Rinvoq.

Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the ... such as J&J's own Tremfya (guselkumab), AbbVie's Skyrizi (risankizumab), and Sun Pharma's ...

“Achieving clear skin is of critical importance in positively ... and AbbVie’s recently-approved Skyrizi (risankizumab) – are already shifting treatment away from older TNF blockers.

The primary objective is to show that we can robustly degrade STAT6 in blood and skin, which we define as ... it was shown that there was a clear -- very clear impact on Th2 biomarkers as well ...

and evenly toned skin achieved by having a regimented routine of products. Contrary to prior belief, clear skin does not equal glass skin, so those with a few blemishes and breakouts can easily ...

AbbVie recently announced the availability of its drug SKYRIZI® in Canada for treating adults with ulcerative colitis, building on Health Canada's prior approval. This significant development may ...

Chia seeds have emerged as a superfood with numerous skin detoxifying benefits. Packed with antioxidants, omega-3 fatty acids, and hydration properties, they help fight inflammation, flush out ...